Previous close | 16.79 |
Open | 16.09 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 15.35 - 16.14 |
52-week range | 11.65 - 21.05 |
Volume | 715,577 |
Avg. volume | 538,723 |
Market cap | 61.601B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 8.52 |
EPS (TTM) | 1.84 |
Earnings date | N/A |
Forward dividend & yield | 0.76 (4.54%) |
Ex-dividend date | 29 Apr 2020 |
1y target est | 18.40 |
Regeneron (REGN) beats on Q4 earnings and sales on solid performance of Dupixent, Eylea and incremental contribution from oncology drug, Libtayo.
Bayer (BAYRY) gets a boost as it wins approvals for a few candidates and enters into collaboration agreements.
Merck (MRK), Glaxo (GSK), AstraZeneca (AZN) and J&J (JNJ) announce FDA approvals.